131I therapy in patients with benign thyroid disease does not conclusively lead to a higher risk of subsequent malignancies;131I-Therapie führt bei Patienten mit benignen Schilddrüsenerkrankungen nicht eindeutig zu einem höheren Risiko auf Folgemalignitäten

NuklearMedizin

Volumn 50, Issue 3, 2011, Pages 93-99

  Verburg, F A ^a   Luster, M ^a   Lassmann, M ^b   Reiners, C ^b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

131I treatment; Benign thyroid disease; Incidence; Malignancy

Indexed keywords

IODINE 131;

CANCER INCIDENCE; DIGESTIVE SYSTEM DISEASE; FOLLOW UP; HUMAN; LATENT PERIOD; MORTALITY; RADIATION ABSORPTION; RADIATION EXPOSURE; REVIEW; RISK ASSESSMENT; THYROID CARCINOMA; THYROID DISEASE;

COMORBIDITY; FEMALE; GRAVES DISEASE; HUMANS; INCIDENCE; IODINE RADIOISOTOPES; MALE; NEOPLASMS, RADIATION-INDUCED; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 79957635673     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/Nukmed-0341-10-08     Document Type: Review

References (25)

1. Cardis E, Howe G, Ron E et al. Cancer consequences of the Chernobyl accident: 20 years on. J Radiol Prot 2006; 26: 127-140.
2. 131I: a population-based cohort study in Sweden. Int J Cancer 2003; 106: 580-587.
3. Farahati J, Demidchik EP, Biko J, Reiners C. Inverse association between age at the time of radiation exposure and extent of disease in cases of radiationinduced childhood thyroid carcinoma in Belarus. Cancer 2000; 88: 1470-1476.
4. Franceschi S, Preston-Martin S, Dal Maso L et al. A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control 1999; 10: 583-595.
5. Franklyn JA, Maisonneuve P, Sheppard MC et al. Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med 1998; 338: 712-718.
6. Franklyn JA, Maisonneuve P, Sheppard M et al. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet 1999; 353: 2111-2115.
7. Franklyn JA, Sheppard MC, Maisonneuve P. Thyroid function and mortality in patients treated for hyperthyroidism. JAMA 2005; 294: 71-80.
8. Freudenberg LS, Muller SP, Bockisch A. Subjective perceptions of patients undergoing radioiodine therapy: why should we know about them? Eur J Nucl Med Mol Imaging 2009; 36: 1743-1744.
9. Hall P, Berg G, Bjelkengren G et al. Cancer mortality after iodine-131 therapy for hyperthyroidism. Int J Cancer 1992; 50: 886-890.
10. Hall P, Lundell G, Holm LE. Mortality in patients treated for hyperthyroidism with iodine-131. Acta Endocrinol (Copenh) 1993; 128: 230-234.
11. Hall P, Mattsson A, Boice JD. Thyroid cancer after diagnostic administration of iodine-131. Radiat Res 1996; 145: 86-92.
12. Hall P, Holm LE. Late consequences of radioiodine for diagnosis and therapy in Sweden. Thyroid 1997; 7: 205-208.
13. Holm LE, Hall P, Wiklund K et al. Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst 1991; 83: 1072-1077.
14. 131I? Nucl Med Commun 2010; 31: 201-205.
15. Lorenz R, Dietlein M, Reiners C. Nuclear medical inpatient treatment in Germany. Nuklearmedizin 2010; 49: 49-57.
16. Lucignani G. Long-term risks in hyperthyroid patients treated with radioiodine: is there anything new? Eur J Nucl Med Mol Imaging 2007; 34: 1504-1509.
17. Metso S, Auvinen A, Huhtala H et al. Increased cancer incidence after radioiodine treatment for hyperthyroidism. Cancer 2007; 109: 1972-1979.
18. Metso S, Jaatinen P, Huhtala H et al. Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism. J Clin Endocrinol Metab 2007; 92: 2190-2196.
19. Pacini F, Vorontsova T, Demidchik EP et al. Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France. J Clin Endocrinol Metab 1997; 82: 3563-3569.
20. Reiners C, Demidchik YE, Drozd VM, Biko J. Thyroid cancer in infants and adolescents after Chernobyl. Minerva Endocrinol 2008; 33: 381-395.
21. Ron E, Lubin JH, Shore RE et al. Thyroid-cancer after exposure to external radiation - A pooled analysis of 7 studies. Radiation Research 1995; 141: 259-277.
22. Ron E, Doody MM, Becker DV et al. for the Cooperative Thyrotoxicosis Therapy Follow-up S. Cancer mortality following treatment for adult hyperthyroidism. JAMA 1998; 280: 347-355.
23. Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med 1998; 338: 297-306.
24. Wendisch M, Drechsel J, Freudenberg R et al. Cellular damage in vitro. Nuklearmedizin 2009; 48: 208-214.
25. Yamashita H, Noguchi S, Watanabe S et al. Thyroid cancer associated with adenomatous goiter: an analysis of the incidence and clinical factors. Surg Today 1997; 27: 495-499.